Altitude training — exposing athletes to reduced oxygen partial pressure, either at natural altitude or through simulated hypoxic environments — has been a tool of elite endurance performance preparation since the 1968 Mexico City Olympics demonstrated that athletes who had acclimatised to altitude performed better at elevation than sea-level athletes. The science of how altitude exposure drives performance-enhancing adaptations, who benefits most, which protocols are most effective, and how simulated altitude compares to natural altitude has been extensively researched over the intervening decades. In 2026, altitude training is better understood than ever — and the evidence base allows more precise protocols and wider access than the natural altitude camps that were previously the only option.
The Physiology: How Altitude Improves Sea-Level Performance
The primary performance-enhancing mechanism of altitude training for endurance athletes is the haematological adaptation to hypoxia: sustained exposure to reduced oxygen stimulates erythropoietin (EPO) production in the kidneys, which drives increased red blood cell production and a higher haemoglobin mass. Higher haemoglobin mass means greater oxygen-carrying capacity at sea level — the athlete returns from altitude with blood that can deliver more oxygen to working muscles at sea level than before altitude exposure, improving VO2 max and endurance performance.
This adaptation begins within the first few days of altitude exposure and continues over 3-4 weeks. The magnitude of the haemoglobin mass increase is directly related to the altitude (higher altitude = stronger EPO stimulus), the duration of exposure (longer camps produce more adaptation), and individual genetic responsiveness (altitude responders show much larger haematological responses to equivalent exposure than non-responders). The performance benefit at sea level — typically 1-3% improvement in aerobic capacity and time-trial performance — persists for approximately 2-4 weeks after return to sea level as the elevated haemoglobin mass slowly decreases toward baseline.
Beyond haematological effects, altitude exposure promotes non-haematological adaptations including improved lactate threshold efficiency, mitochondrial adaptations, and potentially enhanced buffering capacity — adaptations that may contribute to sea-level performance improvements independently of haemoglobin mass changes, though their relative contribution is less well-quantified than the haematological effect.
Live High — Train Low: The Protocol That Changed Everything
The conceptual breakthrough in altitude training science was the live high — train low (LHITL) model, introduced in the 1990s by Ben Levine and James Stray-Gundersen. The problem with simply training at altitude is that the reduced oxygen availability limits the training intensity an athlete can sustain: at 2500m, a runner cannot run as fast as at sea level, meaning the speed-specific neuromuscular and biomechanical training stimuli are compromised. The LHITL model — sleeping and spending passive time at altitude to accumulate hypoxic stimulus, while training at lower altitude where full training intensity is achievable — decouples the haematological stimulus from the training intensity constraint.
Research on LHITL consistently shows that it produces superior sea-level performance improvements compared to continuous altitude training or sea-level training alone. The optimal altitude for living is approximately 2000-2500m — high enough to produce meaningful EPO stimulus, not so high that physiological compromise during rest impairs recovery. Training altitude should be below 1500m to allow full training intensity. The logistical challenge is that relatively few locations naturally provide these altitude differentials at close enough proximity to be practical — which is where simulated altitude technology becomes valuable.
Simulated Altitude: Technology That Has Changed Access
Hypoxic tents and altitude houses — enclosures that reduce oxygen fraction to simulate altitude conditions during sleep — allow athletes to achieve the LHITL model without geographic constraints. An athlete sleeping in a hypoxic tent set to simulate 2500m while training at sea level achieves the essential features of the LHITL model: adequate hypoxic exposure for haematological stimulus (8-12 hours per night of simulated altitude) with full training intensity at sea level. Research comparing natural altitude camps to hypoxic tent protocols of equivalent exposure shows comparable haemoglobin mass increases and sea-level performance improvements. The access advantage is transformative: athletes who cannot afford altitude camps, live far from suitable mountains, or cannot disrupt their training environment for extended camp periods can achieve altitude benefits through tent-based protocols.
Individual Response Variability and Monitoring
Altitude training response is highly individual. Haematological responders — athletes whose EPO and reticulocyte responses to altitude are strong — show sea-level performance improvements of 3-5% from standard protocols. Non-responders show minimal haematological adaptation and therefore much smaller performance benefits. Identifying athlete response phenotype — possible through blood monitoring during and after altitude exposure — allows training programmes to target altitude training resources on athletes who respond most strongly and to calibrate protocol duration and altitude for individual responders. Reticulocyte count measurement (reflecting new red blood cell production) in the first week of altitude exposure is the earliest reliable indicator of haematological response, enabling real-time protocol adjustment rather than waiting until post-altitude performance assessment to evaluate effectiveness.
Add a Comment